Literature DB >> 10677728

The role of the immune response on the development of severe clinical forms of human Chagas disease.

R Corrêa-Oliveira1, J Gomes, E M Lemos, G M Cardoso, D D Reis, S Adad, E Crema, O A Martins-Filho, M O Costa, G Gazzinelli, L M Bahia-Oliveira.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10677728     DOI： 10.1590/S0074-02761999000700042

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN： 0074-0276            Impact factor:   2.743


× No keyword cloud information.
  20 in total

1.  Parasite community interactions: Trypanosoma cruzi and intestinal helminths infecting wild golden lion tamarins Leontopithecus rosalia and golden-headed lion tamarins L. chrysomelas (Callitrichidae, L., 1766).

Authors:  Rafael V Monteiro; James M Dietz; Becky Raboy; Benjamin Beck; Kristel De Vleeschouwer; Kristel D Vleeschouwer; Andrew Baker; Andréia Martins; Ana Maria Jansen
Journal:  Parasitol Res       Date:  2007-08-04       Impact factor: 2.289

2.  Modulation of chagasic cardiomyopathy by interleukin-4: dissociation between inflammation and tissue parasitism.

Authors:  M B Soares; K N Silva-Mota; R S Lima; M C Bellintani; L Pontes-de-Carvalho; R Ribeiro-dos-Santos
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

3.  T-Cell Immunophenotyping and Cytokine Production Analysis in Patients with Chagas Disease 4 Years after Benznidazole Treatment.

Authors:  Mauricio Llaguno; Marcos Vinicius da Silva; Lara Rocha Batista; Djalma Alexandre Alves da Silva; Rodrigo Cunha de Sousa; Luiz Antonio Pertili Rodrigues de Resende; Valdo Jose Dias da Silva; Eliane Lages-Silva; Carlo José Freire Oliveira; Juliana Reis Machado; Denise Bertulucci Rocha Rodrigues; Dalmo Correia; Virmondes Rodrigues
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

4.  Cellular immune response from Chagasic patients to CRA or FRA recombinant antigens of Trypanosoma cruzi.

Authors:  Virginia M B Lorena; Alinne F A Verçosa; Raquel C A Machado; Lucas Moitinho-Silva; Maria G A Cavalcanti; Edimilson D Silva; Antonio G P Ferreira; Rodrigo Correa-Oliveira; Valéria R A Pereira; Yara M Gomes
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

5.  Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice.

Authors:  Shivali Gupta; Nisha Jain Garg
Journal:  PLoS Negl Trop Dis       Date:  2010-08-10

6.  Familial analysis of seropositivity to Trypanosoma cruzi and of clinical forms of Chagas disease.

Authors:  Roseane L Silva-Grecco; Marly A S Balarin; Dalmo Correia; Aluízio Prata; Virmondes Rodrigues
Journal:  Am J Trop Med Hyg       Date:  2010-01       Impact factor: 2.345

7.  Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice.

Authors:  Vandanajay Bhatia; Nisha Jain Garg
Journal:  Clin Vaccine Immunol       Date:  2008-06-11

8.  Deficient regulatory T cell activity and low frequency of IL-17-producing T cells correlate with the extent of cardiomyopathy in human Chagas' disease.

Authors:  Paulo Marcos Matta Guedes; Fredy Roberto Salazar Gutierrez; Grace Kelly Silva; Renata Dellalibera-Joviliano; Gerson Jhonatan Rodrigues; Lusiane Maria Bendhack; Anis Rassi; Anis Rassi; André Schmidt; Benedito Carlos Maciel; José Antonio Marin Neto; João Santana Silva
Journal:  PLoS Negl Trop Dis       Date:  2012-04-24

9.  Benzonidazole therapy modulates interferon-γ and M2 muscarinic receptor autoantibody responses in Trypanosoma cruzi-infected children.

Authors:  Romina A Cutrullis; Guillermo F Moscatelli; Samanta Moroni; Bibiana J Volta; Rita L Cardoni; Jaime M Altcheh; Ricardo S Corral; Héctor L Freilij; Patricia B Petray
Journal:  PLoS One       Date:  2011-10-31       Impact factor: 3.240

Review 10.  Genetic susceptibility to Chagas disease: an overview about the infection and about the association between disease and the immune response genes.

Authors:  Christiane Maria Ayo; Márcia Machado de Oliveira Dalalio; Jeane Eliete Laguila Visentainer; Pâmela Guimarães Reis; Emília Ângela Sippert; Luciana Ribeiro Jarduli; Hugo Vicentin Alves; Ana Maria Sell
Journal:  Biomed Res Int       Date:  2013-08-28       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.